$42.76-$0.23 (-0.54%)
iShares Genomics Immunology and Healthcare ETF’s quoted price sits in the upper half of its reported 52-week range, 2.35% below the high.
Loading market information…
CBOE · GDMN · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
WisdomTree Efficient Gold Plus Gold Miners Strategy Fund’s quoted price sits in the lower half of its reported 52-week range, 56.07% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
WisdomTree Efficient Gold Plus Gold Miners Strategy Fund’s forward annual dividend is $5.28 per share, paid annual. The forward yield is 8.16% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund invests, either directly or through a wholly-owned subsidiary, in a portfolio comprised of (i) U.S.-listed gold futures contracts and (ii) global equity securities issued by companies that derive at least 50% of their revenue from the gold mining business. The fund will invest in a representative basket of global equity securities issued by Gold Miners generally weighted by market capitalization. The fund may invest in U.S. Treasury securities and other liquid short-term investments as collateral for its U.S.-listed gold futures contracts. The fund is non-diversified.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 02:26 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$42.76-$0.23 (-0.54%)
iShares Genomics Immunology and Healthcare ETF’s quoted price sits in the upper half of its reported 52-week range, 2.35% below the high.
$36.00-$0.15 (-0.41%)
Innovator Intl Developed Power Buffer ETF’s quoted price sits in the upper half of its reported 52-week range, 7.64% below the high.
$39.98-$0.11 (-0.27%)
Brandes U.S. Small-Mid Cap Value ETF’s quoted price sits in the upper half of its reported 52-week range, 3.57% below the high.
$62.69-$0.33 (-0.52%)
VictoryShares US Multi-Factor Minimum Volatility ETF’s quoted price sits in the upper half of its reported 52-week range, 1.0% below the high.
$42.69-$0.14 (-0.33%)
Freedom Day Dividend ETF’s quoted price sits in the upper half of its reported 52-week range, 0.95% below the high.
$36.96-$0.90 (-2.38%)
Alpha Architect International Quantitative Momentum ETF’s quoted price sits in the lower half of its reported 52-week range, 19.95% below the high.
$72.26-$0.07 (-0.1%)
WisdomTree Global High Dividend Fund’s quoted price sits in the upper half of its reported 52-week range, 1.7% below the high.
$101.12-$0.60 (-0.59%)
Stratified LargeCap Index ETF’s quoted price sits in the upper half of its reported 52-week range, 0.61% below the high.
